Expert NetworkExpert InterviewREGN

Slingshot members are talking to an expert! The topic is:

Advancing Multiple Myeloma Treatment: Insights into Regeneron's Linvoseltamab in the Phase I/II LINKER-MM1 Study presented at ASH 2023

Executed on:Dec 18, 2023 10:00 AM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Harvard Medical School | Mass General
  • Clinical Director, Center for Multiple Myeloma, Mass General Cancer Center & Assistant Professor of Medicine Harvard Medical School.
  • Manages 350+ patients with multiple myeloma.
  • Principal investigator of several trials in relapsed multiple myelomas, including investigator-initiated trials.

    Interview Goal

    This interview aims to delve into the recent ASH clinical findings concerning Regeneron Pharmaceuticals' bispecific antibody linvoseltamab in the treatment of multiple myeloma. We will focus on understanding the efficacy, safety, and potential impact of this innovative therapy for patients with relapsed/refractory multiple myeloma (RRMM).

    Slingshot Insights Explained

    Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.